{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:00:04Z","timestamp":1791064804845,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T00:00:00Z","timestamp":1277337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T00:00:00Z","timestamp":1277337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2010,10,1]]},"DOI":"10.1038\/jhh.2010.65","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T09:25:01Z","timestamp":1277371501000},"page":"625-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism"],"prefix":"10.1038","volume":"24","author":[{"given":"Z","family":"\u0160oml\u00f3ov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"jr","given":"J","family":"Widimsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wichterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"\u0160trauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Petr\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Zelinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vlkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ma\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dvo\u0159\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Holaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,24]]},"reference":[{"issue":"10","key":"BFjhh201065_CR1","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/HJH.0b013e328302ca38","volume":"26","author":"J Redon","year":"2008","unstructured":"Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S et al. The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens 2008; 26 (10): 1891\u20131900.","journal-title":"J Hypertens"},{"key":"BFjhh201065_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415.","journal-title":"Lancet"},{"key":"BFjhh201065_CR3","first-page":"1462","volume":"28","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462\u20131536.","journal-title":"Eur Heart J"},{"key":"BFjhh201065_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293\u20132300.","journal-title":"J Am Coll Cardiol"},{"key":"BFjhh201065_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","volume":"17","author":"B \u0160trauch","year":"2003","unstructured":"\u0160trauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J . Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003; 17: 349\u2013352.","journal-title":"J Hum Hypertens"},{"key":"BFjhh201065_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ . Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45: 1243\u20131248.","journal-title":"J Am Coll Cardiol"},{"key":"BFjhh201065_CR7","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","volume":"27","author":"GP Rossi","year":"1996","unstructured":"Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039\u20131045.","journal-title":"Hypertension"},{"key":"BFjhh201065_CR8","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295: 2638\u20132645.","journal-title":"JAMA"},{"key":"BFjhh201065_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","volume":"25","author":"R Holaj","year":"2007","unstructured":"Holaj R, Zelinka T, Wichterle D, Petr\u00e1k O, Strauch B, Widimsk\u00fd Jr J . Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 2007; 25: 1451\u20131457.","journal-title":"J Hypertens"},{"key":"BFjhh201065_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.amjhyper.2006.02.002","volume":"19","author":"B Strauch","year":"2006","unstructured":"Strauch B, Petr\u00e1k O, Wichterle D, Zelinka T, Holaj R, Widimsk\u00fd Jr J . Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens 2006; 19: 909\u2013914.","journal-title":"Am J Hypertens"},{"key":"BFjhh201065_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/HYPERTENSIONAHA.107.109439","volume":"51","author":"AW Krug","year":"2008","unstructured":"Krug AW, Ehrhart-Bornstein M . Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension 2008; 51: 1252\u20131258.","journal-title":"Hypertension"},{"key":"BFjhh201065_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","volume":"150","author":"JR Sowers","year":"2009","unstructured":"Sowers JR, Whaley-Connell A, Epstein M . Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150: 776\u2013783.","journal-title":"Ann Intern Med"},{"key":"BFjhh201065_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 2006; 91: 454\u2013459.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201065_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11906-007-0019-1","volume":"9","author":"F Fallo","year":"2007","unstructured":"Fallo F, Federspil G, Veglio F, Mulatero P . The metabolic syndrome in primary aldosteronism. Curr Hypertens Rep 2007; 9: 106\u2013111.","journal-title":"Curr Hypertens Rep"},{"key":"BFjhh201065_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.numecd.2009.03.007","volume":"20","author":"V Ronconi","year":"2010","unstructured":"Ronconi V, Turchi F, Rilli S, Di Mattia D, Agostinelli L, Boscaro M et al. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Nutr Metab Cardiovasc Dis 2010; 20: 93\u2013100.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"BFjhh201065_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","volume":"53","author":"J Matrozova","year":"2009","unstructured":"Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF . Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 2009; 53: 605\u2013610.","journal-title":"Hypertension"},{"key":"BFjhh201065_CR17","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 3266\u20133281.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201065_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KGMM Alberti","year":"2006","unstructured":"Alberti KGMM, Zimmet P, Shaw J . Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469\u2013480.","journal-title":"Diabet Med"},{"key":"BFjhh201065_CR19","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"K Alberti","year":"2009","unstructured":"Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640\u20131645.","journal-title":"Circulation"},{"key":"BFjhh201065_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/01.HYP.5.1.116","volume":"5","author":"D McAreavey","year":"1983","unstructured":"McAreavey D, Murray G, Lever A, Robertson J . Similarity of idiopathic aldosteronism and essential hypertension. A statistical comparison. Hypertension 1983; 5: 116\u2013121.","journal-title":"Hypertension"},{"key":"BFjhh201065_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","volume":"48","author":"M Bochud","year":"2006","unstructured":"Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F et al. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 2006; 48: 239\u2013245.","journal-title":"Hypertension"},{"key":"BFjhh201065_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","volume":"49","author":"S Kidambi","year":"2007","unstructured":"Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ et al. Association of adrenal steroids with hypertension and the metabolic syndrome in Blacks. Hypertension 2007; 49: 704\u2013711.","journal-title":"Hypertension"},{"key":"BFjhh201065_CR23","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1210\/jc.2008-0251","volume":"93","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Belfiore A, Bernini G, Fabris B, Caridi G, Ferri C et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab 2008; 93: 2566\u20132571.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201065_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03498.x","volume":"71","author":"G Lastra-Lastra","year":"2009","unstructured":"Lastra-Lastra G, Sowers JR, Restrepo-Erazo K, Manrique-Acevedo C, Lastra-Gonz\u00e1lez G . Role of aldosterone and angiotensin II in insulin resistance: an update. Clin Endocrinol 2009; 71: 1\u20136.","journal-title":"Clin Endocrinol"},{"key":"BFjhh201065_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.tem.2009.05.006","volume":"20","author":"M Zennaro","year":"2009","unstructured":"Zennaro M, Caprio M, F\u00e8ve B . Mineralocorticoid receptors in the metabolic syndrome. Trends Endocrinol Metab 2009; 20: 444\u2013451.","journal-title":"Trends Endocrinol Metab"},{"key":"BFjhh201065_CR26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2337\/diabetes.49.11.1751","volume":"49","author":"JC Henquin","year":"2000","unstructured":"Henquin JC . Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000; 49: 1751\u20131760.","journal-title":"Diabetes"},{"key":"BFjhh201065_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","volume":"20","author":"F Fallo","year":"2007","unstructured":"Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 2007; 20: 855\u2013861.","journal-title":"Am J Hypertens"},{"key":"BFjhh201065_CR28","first-page":"21","volume":"108","author":"G Sindelka","year":"2000","unstructured":"Sindelka G, Widimsk\u00fd J, Haas T, Pr\u00e1zn\u00fd M, Hilgertov\u00e1 J, Skrha J . Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabetes 2000; 108: 21\u201325.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BFjhh201065_CR29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33549\/physiolres.930123","volume":"50","author":"J Widimsk\u00fd","year":"2001","unstructured":"Widimsk\u00fd J, Strauch B, Sindelka G, Skrha J . Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol Res 2001; 50: 603\u2013607.","journal-title":"Physiol Res"},{"key":"BFjhh201065_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11892-008-0009-y","volume":"8","author":"F Fallo","year":"2008","unstructured":"Fallo F, Federspil G, Veglio F, Mulatero P . The metabolic syndrome in primary aldosteronism. Curr Diab Rep 2008; 8: 42\u201347.","journal-title":"Curr Diab Rep"},{"key":"BFjhh201065_CR31","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1210\/jc.2006-0736","volume":"91","author":"C Catena","year":"2006","unstructured":"Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M et al. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 2006; 91: 3457\u20133463.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFjhh201065_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/157016109787455716","volume":"7","author":"G Giacchetti","year":"2009","unstructured":"Giacchetti G, Turchi F, Boscaro M, Ronconi V . Management of primary aldosteronism: its complications and their outcomes after treatment. Curr Vasc Pharmacol 2009; 7: 244\u2013249.","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201065","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T06:17:56Z","timestamp":1740205076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,24]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10,1]]}},"alternative-id":["BFjhh201065"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2010.65","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,24]]},"assertion":[{"value":"4 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}